Determination of Lipid Derangements in Human Immunodeficiency Virus Patients Undergoing Anti-Retroviral Therapy

  • Qamar Bashir Armed Forces Institute of Pathology/ National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Zujaja Hina Haroon Armed Forces Institute of Pathology/ National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Naveed Asif Combined Military Hospital, Quetta/National University of Medical Sciences (NUMS) Pakistan
  • Muhammad Qaiser Alam Khan Combined Military Hospital, Lahore/National University of Medical Sciences (NUMS) Pakistan
  • Eijaz Ghani Armed Forces Institute of Pathology/ National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Syed Raza Jaffar Armed Forces Institute of Pathology/ National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Keywords: Acquired immunodeficiency syndrome (AIDS), Antiretroviral therapy (ART), Cholesterol, Human immunodeficiency virus (HIV), hyperlipidemia

Abstract

Objective: To determine lipid derangements in HIV-positive patients receiving anti-retroviral therapy (ART).

Study Design: Comparative cross-sectional study.

Place and Duration of study: Chemical Pathology Department, in cooperation with the Department of Virology at Armed Forces Institute of Pathology (AFIP), Rawalpindi Pakistan, from Mar 2019 to Mar 2020.

Methodology: In this study, two groups were made. In Group-1, lipid profile estimation was done in HIV patients without treatment. In contrast, lipid profile estimation was done after one year of treatment with anti-retroviral drugs in Group-2.

Results: One hundred and two HIV-positive subjects were included in our study. Of these patients, 88(86.27%) were males,and 14(13.73%) were females. Independent sample t-test revealed a statistically significant difference (p-value<0.05) in serum cholesterol, serum triglycerides, serum high-density lipoprotein (HDL-c), low-density lipoproteins (LDL) and very lowdensity lipoproteins (VLDL) between the two groups.

Conclusion: Hyperlipidemia in HIV patients getting anti-retroviral therapy (ART) exposes them to a high risk of coronary artery diseases and myocardial infarction. Hence lipid profile of patients getting ART must be regularly monitored, and hyperlipidemia, if present, should be managed.

Downloads

Download data is not yet available.
Published
2022-12-29
How to Cite
Bashir, Q., Haroon, Z. H., Asif, N., Alam Khan, M. Q., Ghani, E., & Jaffar, S. R. (2022). Determination of Lipid Derangements in Human Immunodeficiency Virus Patients Undergoing Anti-Retroviral Therapy. Pakistan Armed Forces Medical Journal, 72(6), 1871-73. https://doi.org/10.51253/pafmj.v72i6.5810
Section
Original Articles